Physician

John Michael Houri, M.D.

According to 2025 Medicare claims, John Houri, M.D. (NPI: 1609895101) practices rheumatology in the Port St. Lucie, FL market, with the plurality of this provider's patient population coming from Martin, FL. This provider's primary affiliated billing organization is RHEUMATOLOGY ASSOCIATES PA (NPI: 1346451432; TIN: 591692055) and primary practice location at 34996-3301.

Houri's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,001 traditional Medicare patients, billed 133,433 HCPCS/CPT codes, and received $1,970,735 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,916 prescription claims across 452 beneficiaries totaling $1,021,695 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 12 records totaling $221. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $589,463 to $1,970,735. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,052	54,763	$589,463
2016	1,084	80,448	$783,350
2017	990	73,283	$741,091
2018	992	102,475	$1,351,091
2019	919	123,072	$1,697,760
2020	922	105,777	$1,835,985
2021	979	107,576	$1,548,775
2022	982	117,499	$1,623,363
2023	984	109,577	$1,699,543
2024	1,001	133,433	$1,970,735

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	532	3,784	$841,556
2016	554	4,158	$1,068,249
2017	535	3,843	$1,083,689
2018	500	3,684	$1,201,607
2019	470	3,352	$1,121,632
2020	492	3,534	$1,155,903
2021	503	3,427	$989,910
2022	478	3,217	$966,515
2023	452	2,917	$1,087,000
2024	452	2,916	$1,021,695

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	528	937	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	619	1,120	$64
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	236	605	$56
J0897	Injection, denosumab, 1 mg	199	19,320	$20
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	851	1,868	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	36	1,012	$244,702
Enbrel Sureclick	Etanercept	23	700	$170,766
Cosentyx Syringe	Secukinumab	13	364	$93,646
Orencia Clickject	Abatacept	13	364	$77,432
Benlysta	Belimumab	15	420	$64,945

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$221	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John Michael Houri, M.D.?

Tedicare shows public-source Medicare data for John Michael Houri, M.D. (NPI 1609895101), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Michael Houri, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Michael Houri, M.D.?

John Michael Houri, M.D. is linked to RHEUMATOLOGY ASSOCIATES PA (billing NPI 1346451432) in the available physician profile data.

Does John Michael Houri, M.D. have Open Payments data?

John Michael Houri, M.D. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.